Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Antimicrobial surfaces to reduce bacterial build-up on medical instruments

International Day for Biological Diversity – May 22, 2021

Diabetic patients and Covid-19 pandemic

Antimicrobial surfaces to reduce bacterial build-up on medical instruments
  • BiotechToday
  • World

Antimicrobial surfaces to reduce bacterial build-up on medical instruments

bioxone May 22, 2021May 22, 2021

Aakancha Shaw, St. Xavier’s College, Kolkata

The researchers of Monash University have developed new antimicrobial surfaces that can efficiently reduce the formation of bacteria on medical instruments, including urinary catheters, and hence can reduce the risk of patient infection while in hospital.

This world-class study proves the ability of these 3D-engineered surfaces in preventing the formation and growth of colonies of microorganisms like Escherichia coli (E.coli), Pseudomonas aeruginosa, and Klebsiella pneumoniae. These are the three most common types of urinary tract bacterial infections (UTIs) associated with catheters. The study team was led by Dr. Victor Cadarso, Department of Mechanical and Aerospace Engineering, and the Center to Impact AMR, Monash University. Engineered surfaces with 3D smooth micro features instead of the traditional sharp cross-sectional ones were a breakthrough to reduce the potential for harmful bacteria to attach to the surfaces in huge numbers.

The surfaces that were tested were found to show a reduction in both attachments of bacteria and biofilm formation. One of the surfaces that were considered, P01, presented excellent properties against E.coli(55 percent fewer bacterial cells attached, 53 percent fewer microcolonies being formed), K.pneumoniae(69 percent fewer bacterial cells attached, 77 percent fewer microcolonies being formed), and P. aeruginosa (68 percent less bacterial cells attached, 66 percent fewer microcolonies being formed). Urinary tract infections (UTIs), caused due to urinary catheters, are one of the most common types of healthcare-associated infections and have been identified by the World Health Organization (WHO) as an urgent global health threat. Approximately 13000 people die each year from UTIs and around 7 Lakh people die from related antimicrobial resistance infections. This is because of the resistance of superbugs to current sterilization practices and to antibiotics. 

Using E.coli the researchers found bacterial cells that form on surfaces, mostly on the sharp corners. Hence, by successfully removing these sharp features, the bacteria can no longer colonize the surface effectively. This same effect was demonstrated for the two other pathogens- Pseudomonas aeruginosa and Klebsiella pneumoniae. in this study. Surfaces such as catheters and ventilators are a significant source of microbial spread and associated infections. So, a smarter approach would be physically altering the architecture of these surfaces instead of using chemical agents. The former is a more effective strategy for fighting antimicrobial resistance

The bacterial colonization of surfaces takes place gradually. As bacteria attach to a surface, cellular responses are triggered and a few rounds of cell division results in the formation of microcolonies of such bacterial cells. After this successful colonization, the bacterial colonies form a biofilm. Biofilm is a large population of bacteria in a matrix that binds together and protects the cells from the immune system. This might create a superbug that can cause long-term health complications for patients. The researchers found out that the sharp corners of various medical instruments provide hiding spots for the bacteria and by smoothing these corners, the bacteria would get no place to hide. 

Hence, researchers developed such great strategies for the prevention of bacterial colonization of surfaces like catheters, and is very important to prevent the potential spreading of harmful diseases.

Also read: International Day for Biological Diversity – May 22, 2021

Reference- Three-Dimensional Micropatterning Deters Early Bacterial Adherence and Can Eliminate Colonization

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Antibiotic antimicrobial bacteria biofilm Catheter superbug UTI

2 thoughts on “Antimicrobial surfaces to reduce bacterial build-up on medical instruments”

  1. Pingback: Diabetic patients and Covid-19 pandemic - BioXone
  2. Pingback: C28 : Controls the side effects of drugs on the Heart - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Diabetic patients and Covid-19 pandemic

bioxone May 22, 2021

Husna, Amity University Kolkata COVID-19 is a highly contagious viral infection that can mainly affect the respiratory system. It is caused by the SARS-CoV-2 virus which has the ability to mutate. Due to frequent mutations, the COVID-19 strains are highly virulent and tend to infect more rapidly, leading to a rapidly evolving pandemic. The impact […]

Diabetic

Related Post

  • BiotechToday
  • World

Differentiation pathways in human Treg cells revealed

BioTech Today June 26, 2021June 25, 2021

Akash Singh, Banaras Hindu University Immune tolerance relies on FOXP3+ regulatory T (Treg) cells in humans. Their heterogeneity and distinction, on the other hand, have always been a point of contention. A Chinese research team has used single-cell RNA (scRNA) and T cell receptor sequencing to isolate Treg cells from healthy people and stem cell […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Genetically modified mosquitoes to control the Zika virus?

bioxone February 4, 2021February 4, 2021

Prama Ghosh, Amity University Kolkata The Zika virus epidemic was a public health emergency, causing birth defects for pregnant women in addition to neurological problems. The virus gets transmitted to humans from female mosquito bites. Researchers have tried several techniques to eliminate the spread of the virus, one of which is the use of genetically […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Molnupiravir: The real game-changer for COVID-19?

bioxone March 20, 2021March 20, 2021

Shagufta Hasan, Amity University Kolkata  The world has had hard knocks with COVID-19 vaccines but no drug seems to give full coverage against the virus, but now, it may hope for good news. A new drug, Molnupiravir, has been developed by Merck & Co. Inc in association with Ridgeback Biotherapeutics, a biotechnology company, focused on […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy